Literature DB >> 24214371

Modeling thrombin generation: plasma composition based approach.

Kathleen E Brummel-Ziedins1, Stephen J Everse, Kenneth G Mann, Thomas Orfeo.   

Abstract

Thrombin has multiple functions in blood coagulation and its regulation is central to maintaining the balance between hemorrhage and thrombosis. Empirical and computational methods that capture thrombin generation can provide advancements to current clinical screening of the hemostatic balance at the level of the individual. In any individual, procoagulant and anticoagulant factor levels together act to generate a unique coagulation phenotype (net balance) that is reflective of the sum of its developmental, environmental, genetic, nutritional and pharmacological influences. Defining such thrombin phenotypes may provide a means to track disease progression pre-crisis. In this review we briefly describe thrombin function, methods for assessing thrombin dynamics as a phenotypic marker, computationally derived thrombin phenotypes versus determined clinical phenotypes, the boundaries of normal range thrombin generation using plasma composition based approaches and the feasibility of these approaches for predicting risk.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24214371     DOI: 10.1007/s11239-013-1006-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  125 in total

1.  A computational analysis of FXa generation by TF:FVIIa on the surface of rat vascular smooth muscle cells.

Authors:  C L Hall; S M Slack; V T Turitto
Journal:  Ann Biomed Eng       Date:  1998 Jan-Feb       Impact factor: 3.934

2.  A model for the formation, growth, and lysis of clots in quiescent plasma. A comparison between the effects of antithrombin III deficiency and protein C deficiency.

Authors:  M Anand; K Rajagopal; K R Rajagopal
Journal:  J Theor Biol       Date:  2008-04-25       Impact factor: 2.691

3.  Thrombin generation and bleeding in haemophilia A.

Authors:  K E Brummel-Ziedins; M F Whelihan; M Gissel; K G Mann; G E Rivard
Journal:  Haemophilia       Date:  2009-06-26       Impact factor: 4.287

4.  Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition.

Authors:  Anetta Undas; Matthew Gissel; Beata Kwasny-Krochin; Piotr Gluszko; Kenneth G Mann; Kathleen E Brummel-Ziedins
Journal:  Thromb Haemost       Date:  2010-06-30       Impact factor: 5.249

5.  Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia.

Authors:  Geoffrey A Allen; Maureane Hoffman; Harold R Roberts; Dougald M Monroe
Journal:  Br J Haematol       Date:  2006-06-20       Impact factor: 6.998

6.  Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.

Authors:  G Spraggon; S J Everse; R F Doolittle
Journal:  Nature       Date:  1997-10-02       Impact factor: 49.962

Review 7.  Natural anticoagulants, aging, and thromboembolism.

Authors:  A Sagripanti; A Carpi
Journal:  Exp Gerontol       Date:  1998 Nov-Dec       Impact factor: 4.032

8.  Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice.

Authors:  J Xue; Q Wu; L A Westfield; E A Tuley; D Lu; Q Zhang; K Shim; X Zheng; J E Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

Review 9.  The use of microfluidics in hemostasis: clinical diagnostics and biomimetic models of vascular injury.

Authors:  Keith B Neeves; Abimbola A Onasoga; Adam R Wufsus
Journal:  Curr Opin Hematol       Date:  2013-09       Impact factor: 3.284

10.  From principle to practice: bridging the gap in patient profiling.

Authors:  Jonathan H Foley; Thomas Orfeo; Anetta Undas; Kelley C McLean; Ira M Bernstein; Georges-Etienne Rivard; Kenneth G Mann; Stephen J Everse; Kathleen E Brummel-Ziedins
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more
  9 in total

Review 1.  Novel mediators and biomarkers of thrombosis.

Authors:  Travis Sexton; Susan S Smyth
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

2.  Real-time measurement of thrombin generation using continuous droplet microfluidics.

Authors:  Jiaqing Yu; Ding Tao; Ee Xing Ng; Chester L Drum; Ai Qun Liu; Chia-Hung Chen
Journal:  Biomicrofluidics       Date:  2014-09-03       Impact factor: 2.800

Review 3.  Systems Analysis of Thrombus Formation.

Authors:  Scott L Diamond
Journal:  Circ Res       Date:  2016-04-29       Impact factor: 17.367

Review 4.  Global assays of hemostasis.

Authors:  Kathleen E Brummel-Ziedins; Alisa S Wolberg
Journal:  Curr Opin Hematol       Date:  2014-09       Impact factor: 3.284

Review 5.  Computationally Driven Discovery in Coagulation.

Authors:  Kathryn G Link; Michael T Stobb; Dougald M Monroe; Aaron L Fogelson; Keith B Neeves; Suzanne S Sindi; Karin Leiderman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-29       Impact factor: 8.311

6.  Mechanistic Modeling of the Effects of Acidosis on Thrombin Generation.

Authors:  Alexander Y Mitrophanov; Frits R Rosendaal; Jaques Reifman
Journal:  Anesth Analg       Date:  2015-08       Impact factor: 5.108

7.  Semi-automated thrombin dynamics applying the ST Genesia thrombin generation assay.

Authors:  Audrey Carlo; Qiuting Yan; Hugo Ten Cate; Romy De Laat-Kremers; Bas De Laat; Marisa Ninivaggi
Journal:  Front Cardiovasc Med       Date:  2022-07-26

8.  Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots.

Authors:  Laily D Zubairova; Roza M Nabiullina; Chandrasekaran Nagaswami; Yuriy F Zuev; Ilshat G Mustafin; Rustem I Litvinov; John W Weisel
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

9.  A Comparison of Healthy Infants and Adults with Respect to Indirect Microparticle Activity and the Parameters of the Thrombin Generation Test.

Authors:  Filiz Şimşek Orhon; Nejat Akar; Yonca Eğin; Betül Ulukol; Sevgi Başkan
Journal:  Turk J Haematol       Date:  2016-04-18       Impact factor: 1.831

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.